Skip to content
Trial Eligibility
Menu

Neuromodulation of Mood Switch Circuitry in Bipolar Disorder

NCT07680153

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study is exploring a new approach to treating depression in people with bipolar disorder (BD). Investigators are testing whether a non-invasive form of brain stimulation can help us understand depressed-to-euthymic mood shifts and their related brain circuits in BD. Investigators in this study will use a technique called repetitive transcranial magnetic stimulation, or rTMS. It uses non-invasive magnetic pulses delivered to the scalp to stimulate specific areas of the brain.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Bipolar Disorder (BD)
  • Bipolar 1 Depression
  • rTMS
  • fMRI

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 to 70 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Weill Medical College of Cornell University
Last updated on ClinicalTrials.gov
September 23, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Weill Cornell Medicine · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.